Patent directory · USPTO A61K / A61P
Patents matching “REGENXBIO INC.”
4 pharma patents match "REGENXBIO INC." in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 4 pharmaceutical patents matching "REGENXBIO INC." in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 12247213
Treatment of mucopolysaccharidosis IVA
granted -
US 12070510
Injection of single-stranded or self-complementary adeno-associated virus 9 into the cerebrospinal fluid
granted -
US 11986515
Treatment of mucopolysaccharidosis II with recombinant human iduronate-2-sulfatase (IDS)
granted -
US 11613739
Treatment of mucopolysaccharidosis II with recombinant human iduronate-2-sulfatase (IDS) produced by human neural or glial cells
granted